ZLZhiyong Lei

Zhiyong Lei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiyong Lei has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Joost Petrus Gerardus Sluijter

    Department of Cardiology and Experimental Cardiology Laboratory, Division of Heart & Lungs, University Medical Centre Utrecht, Utrecht, the Netherlands

    8 shared publications
  • Raymond Schiffelers

    CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands

    7 shared publications
  • Qiangbing Yang

    CDL Research, University Medical Center Utrecht, Utrecht, the Netherlands

    5 shared publications
  • Alain van Mil

    Experimental Cardiology Laboratory, department of Cardiology, division of Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands; Regenerative Medicine Center Utrecht, Circulatory Health Research Center, University Medical Center Utrecht, University Utrecht, the Netherlands

    4 shared publications
  • Joost P.G. Sluijter

    Department of Cardiology, Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands

    4 shared publications
  • Juntao Fang

    Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    4 shared publications

Latest Publications

  • Open Access

    Increased Nuclear Susceptibility to Mechanical Stress in Phospholamban R14del Cardiomyopathy: A New Perspective on Disease Heterogeneity

    by Jort S. A. van der Geest, Atze van der Pol, Leon Hermans, Achmed Al-Khaqani, Jeroen van Asten, Marlinne A.M.E. van Roessel, Willem B. van Ham, Anneline S.J.M. Te Riele, Alain van Mil, Vasco Sampaio-Pinto, et al.

    Background: Clinical presentation of phospholamban (PLN) R14del cardiomyopathy is highly variable, from asymptomatic carriers to rapidly progressing heart failure. which cannot be fully explained by its known disturbance of sarcoplasmic reticulum calcium handling. Nuclear calcium signalling, shaped by sarcoplasmic reticulum calcium release, plays a key role in regulating gene expression and the cellular response to mechanical stress. However, how the R14del variant affects nuclear signalling under mechanical loading remains unclear. Objective: To uncover the impact of the PLN R14del variation on mechanosensing, nuclear calcium handling and its link to the variable clinical representation of this cardiomyopathy. Methods: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) carrying the PLN R14del variant, an isogenic control, and wildtype control were subjected to mechanical stimulation by cyclic stretch or cultured on substrates with physiological (10-20 kPa) and pathological (65-85 kPa) stiffness. Nuclear morphology, cytoskeletal organisation and nuclear body formation were assessed via immunofluorescence. Traction force microscopy was used to assess mechanical stress and force generation. Cardiac tissues from PLN R14del cardiomyopathy patients, dilated cardiomyopathy patients, and healthy controls were analysed under mechanical loading (at left ventricular assist device implantation) and unloading (at heart transplantation). Living myocardial slices from a PLN R14del patient were maintained under overloading or physiological loading conditions. Results: PLN R14del hiPSC-CMs showed impaired nuclear calcium handling and, under mechanical stress, exhibited impaired mechanotransduction and elevated nuclear bodies. A strain-avoidance response was triggered but failed to prevent apoptosis. Nuclear abnormalities were confirmed in patient myocardial slices and cardiac biopsies which normalized upon relative mechanical unloading. Conclusion: PLN R14del increases nuclear susceptibility to mechanical stress, linking nuclear dysfunction to new disease insights and highlighting potential for mechanobiology-based therapeutic interventions. Condensed PLN R14del cardiomyopathy presents with highly variable clinical severity, which cannot be fully explained by its known disturbance of sarcoplasmic reticulum calcium handling. We investigated whether the R14del variant impairs nuclear calcium signalling and mechanosensing, thereby contributing to disease heterogeneity. Using PLN R14del, isogenic control, and wildtype hiPSC-CMs subjected to cyclic stretch and substrates of physiological and pathological stiffness, we demonstrate that PLN R14del cardiomyocytes exhibit impaired nuclear calcium handling, elevated nuclear damage, disrupted cytoskeletal organisation, and failed mechanotransduction under mechanical stress. Although a strain-avoidance response was triggered, it was insufficient to prevent apoptosis. These findings were confirmed in living myocardial slices and cardiac biopsies from PLN R14del patients, where nuclear abnormalities were most pronounced under mechanical loading and reversed upon unloading. Together, these data establish increased nuclear susceptibility to mechanical stress as a novel pathological feature of PLN R14del cardiomyopathy, offering new insight into disease heterogeneity and highlighting mechanobiology-based therapeutic opportunities.

  • Open Access

    NEO-AAV: an engineered extracellular vesicle-enveloped AAV platform for activation-coupled T cell transduction and CAR-T cell generation

    by Songpu Xie, Qiangbing Yang, Lisa V. Jansen, Bing Yao, Geng Yang, Kaiyong Qu, Pieter Vader, Christian Snijders Blok, Saskia C.A. de Jager, Gerard J.J. Boink, et al.

    Efficient delivery of genetic cargo to primary human T cells remains a critical barrier for cell-based immunotherapies. AAVs are widely used but limited by immune neutralization and poor T cell transduction efficiency. We present NEO-AAV, an engineered fusion protein (PH–ALG2–PKD12) that recruits AAV capsids into endogenous extracellular vesicles (EVs) via PI(4,5)P2-directed membrane targeting, multivalent PKD12–capsid clustering, and ALG2-mediated ESCRT machinery recruitment, yielding EV-enveloped particles with improved AAV loading compared with passive EV-AAV controls. NEO-AAV displayed enhanced resistance to an anti-AAV6 neutralizing antibody (ADK6), maintaining transduction at concentrations that neutralized naked AAV6 and outperformed passively formed EV-AAV6. Surface display of a CD7/CD3/CD28 tri-chimera enabled single-step activation and transduction of CD7⁺ T cells within PBMCs, reaching ∼38% eGFP⁺ cells without exogenous pre-activation. As a proof-of-concept, NEO-AAV generated functional CAR-T cells from primary human PBMCs, exhibiting antigen-specific IFN-γ release and cytotoxicity against CD19 + target cells. CAR expression peaked at day 5 and declined by day 15, consistent with episomal AAV kinetics, framing NEO-AAV as an activation-coupled delivery module rather than a durable solution. Together, NEO-AAV provides a programmable EV-enveloped AAV platform with improved immune shielding and single-step T cell transduction, offering a building block for immune cell engineering with in vivo potential.

  • Open Access

    Photoporation enables non-viral delivery of prime editing RNP complexes into human iPSC-derived cardiomyocytes for cardiac genome correction

    by Bing Yao, Geng Yang, Qian Wang, Mark A. Daniels, Inge Dokter, Peng Shang, Alain van Mil, Pieter A. Doevendans, Manuel A.F.V. Gonçalves, Francesca Stillitano, et al.

  • Open Access

    LAH5-mediated delivery of prime editor ribonucleoprotein complexes for genome editing

    by Bing Yao, Mert Öktem, Geng Yang, Qian Wang, Mark A. Daniels, Inge Dokter, Juliet W. Lefferts, Manuel A.F.V. Gonçalves, Pieter A. Doevendans, Alain van Mil, et al.


  • Open Access

    Enhancing cardiomyocyte reprogramming efficiency by targeting cellular senescence is mediated via Rb1 gene

    by Juntao Fang, Qiangbing Yang, Renée G. C. Maas, Pieter Vader, Michal Mokry, Noortje A. M. van Den Dungen, Li Qian, Junjie Xiao, Raymond Schiffelers, Zhiyong Lei, et al.

    Introduction: Direct reprogramming of fibroblasts into cardiomyocytes by overexpressing cardiac transcription factors Gata4, Mef2c, and Tbx5 (GMT) is a promising way for cardiac repair, however, the low reprogramming efficiency remains a significant challenge. Cellular senescence, an irreversible cell-cycle arrest occurring in mitotic cells, has been reported to influence the efficiency of induced pluripotent stem cell (iPSC) reprogramming. Methods: We established an inducible GMT expression system in mouse embryonic fibroblasts (MEFs) and human fetal cardiac fibroblasts (hFCFs) using the PiggyBac transposon system. RNA sequencing was performed to identify genes associated with cellular senescence during reprogramming. Selected senescence-related genes were knocked down using shRNA, and their impact on reprogramming efficiency was assessed via flow cytometry, gene expression analysis, and staining for senescence and apoptosis markers. Results: Direct cardiac reprogramming induced cellular senescence and apoptosis, evidenced by enhanced β-Gal staining, elevated expression of senescence markers P16 and GLB1, and increased apoptosis rates. RNA sequencing and gene set enrichment analysis (GSEA) revealed significant upregulation of senescence-related genes (RB1, RBBP4, RBBP7, CBX8, and CDKN1B). Knockdown of these genes, particularly RB1, significantly enhanced reprogramming efficiency, increasing the proportion of GFP + cells in MEFs and α-actinin + cells in hFCFs. RB1 inhibition also reduced senescence marker levels and upregulated endogenous cardiac transcription factors GATA4 and MEF2C. Conclusions: Our findings demonstrate that cellular senescence might serves as a barrier to direct cardiac reprogramming and offer novel insights into the regulatory mechanisms involved in this process.


  • Open Access

    Insights into pegRNA design from editing of the cardiomyopathy‐associated phospholamban R14del mutation

    by Bing Yao, Qiangbing Yang, Christian J.B. Snijders Blok, Mark A. Daniels, Pieter A. Doevendans, Raymond Schiffelers, Joost P.G. Sluijter, Zhiyong Lei

    Prime editing (PE) represents a transformative genome‐editing technology and enables precise insertions, deletions, and base substitutions without introducing double‐strand breaks, thereby reducing undesired indels and off‐target effects. Despite advancements in enhanced prime editors and optimized prime editing guide RNAs (pegRNAs), designing effective pegRNAs remains a major challenge. The phospholamban ( PLN ) R14del mutation is associated with cardiomyopathies, making it a crucial target for precise gene‐editing strategies. In this study, we explored pegRNA features that contribute to high editing efficiency using the FluoPEER. PLN R14del reporter cell line. Through systematic screening, we identified three pegRNAs with significantly enhanced editing efficiency. Our findings underscore the importance of pegRNA secondary structure and stability in optimizing prime editing, providing valuable insights into precise gene correction strategies.


  • Open Access

    Lipopeptide-mediated delivery of CRISPR/Cas9 ribonucleoprotein complexes for gene editing and correction

    by Mert Öktem, Thai Hoang Nguyen, Esmeralda D.C. Bosman, Marcel H.A.M. Fens, Massimiliano Caiazzo, Enrico Mastrobattista, Zhiyong Lei, Olivier G. de Jong


  • Open Access

    Comparative Analysis of Methods for Assessing On-Target Gene Editing Efficiencies

    by Bing Yao, Qiangbing Yang, Manuel A. F. V. Gonçalves, Raymond Schiffelers, Joost P. G. Sluijter, Zhiyong Lei

    Genome editing based on CRISPR-derived technologies has become a cornerstone in both fundamental research and clinical applications. Accurately measuring editing efficiency is crucial for developing and applying genome editing strategies. This study offers a detailed comparison of widely used techniques for evaluating on-target gene editing efficiency, including T7 Endonuclease I (T7EI), Tracking of Indels by Decomposition (TIDE), Inference of CRISPR Edits (ICE), droplet digital PCR (ddPCR), and live-cell assays involving engineered fluorescent reporter cells. Through a comparative analysis, this study highlights the unique strengths and limitations of each method, aiding researchers in choosing the most appropriate method for their specific needs, ensuring more tailored monitoring of genome editing outcomes in a precise and reliable manner.


  • Open Access

    Correction: Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species

    by Juntao Fang, Qiangbing Yang, Renée G. C. Maas, Michele Buono, Bram Meijlink, Dyonne Lotgerink Bruinenberg, Ernest Diez Benavente, Michal Mokry, Alain van Mil, Li Qian, et al.

  • Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells

    by Jing Wang, Shuqin Liu, Xinxiu Meng, Xuan Zhao, Tianhui Wang, Zhiyong Lei, H. Immo Lehmann, Guoping Li, Pilar Alcaide, Yihua Bei, et al.

    BACKGROUND: Doxorubicin is an effective chemotherapeutic agent, but its use is limited by acute and chronic cardiotoxicity. Exercise training has been shown to protect against doxorubicin-induced cardiotoxicity, but the involvement of immune cells remains unclear. This study aimed to investigate the role of exercise-derived B cells in protecting against doxorubicin-induced cardiotoxicity and to further determine whether B cell activation and antibody secretion play a role in this protection. METHODS: Mice that were administered with doxorubicin (5 mg/kg per week, 20 mg/kg cumulative dose) received treadmill running exercise. The adoptive transfer of exercise-derived splenic B cells to μMT −/− (B cell–deficient) mice was performed to elucidate the mechanism of B cell regulation that mediated the effect of exercise. RESULTS: Doxorubicin-administered mice that had undergone exercise training showed improved cardiac function, and low levels of cardiac apoptosis, atrophy, and fibrosis, and had reduced cardiac antibody deposition and proinflammatory responses. Similarly, B cell pharmacological and genetic depletion alleviated doxorubicin-induced cardiotoxicity, which phenocopied the protection of exercise. In vitro performed coculture experiments confirmed that exercise-derived B cells reduced cardiomyocyte apoptosis and fibroblast activation compared with control B cells. Importantly, the protective effect of exercise on B cells was confirmed by the adoptive transfer of splenic B cells from exercised donor mice to μMT −/− recipient mice. However, blockage of Fc gamma receptor IIB function using B cell transplants from exercised Fc gamma receptor IIB −/− mice abolished the protection of exercise-derived B cells against doxorubicin-induced cardiotoxicity. Mechanistically, we found that Fc gamma receptor IIB, an important B cell inhibitory receptor, responded to exercise and increased B cell activation threshold, which participated in exercise-induced protection against doxorubicin-induced cardiotoxicity. CONCLUSIONS: Our results demonstrate that exercise training protects against doxorubicin-induced cardiotoxicity by upregulating Fc gamma receptor IIB expression in B cells, which plays an important anti-inflammatory role and participates in the protective effect of exercise against doxorubicin-induced cardiotoxicity.